Octavio Espinoza - 30 Jun 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
By: /s/ Andrew Reardon For: Octavio Espinoza
Issuer symbol
LGND
Transactions as of
30 Jun 2023
Net transactions value
+$21,292
Form type
4
Filing time
10 Jul 2023, 18:42:39 UTC
Previous filing
27 Feb 2023
Next filing
03 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Other $21,292 +375 +1.6% $56.78 24,517 30 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).